364 related articles for article (PubMed ID: 7530484)
1. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.
Cher ML; MacGrogan D; Bookstein R; Brown JA; Jenkins RB; Jensen RH
Genes Chromosomes Cancer; 1994 Nov; 11(3):153-62. PubMed ID: 7530484
[TBL] [Abstract][Full Text] [Related]
2. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
Korn WM; Yasutake T; Kuo WL; Warren RS; Collins C; Tomita M; Gray J; Waldman FM
Genes Chromosomes Cancer; 1999 Jun; 25(2):82-90. PubMed ID: 10337990
[TBL] [Abstract][Full Text] [Related]
3. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
Van Dekken H; Krijtenburg PJ; Alers JC
Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
5. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization.
Joos S; Bergerheim US; Pan Y; Matsuyama H; Bentz M; du Manoir S; Lichter P
Genes Chromosomes Cancer; 1995 Dec; 14(4):267-76. PubMed ID: 8605115
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.
Macoska JA; Trybus TM; Sakr WA; Wolf MC; Benson PD; Powell IJ; Pontes JE
Cancer Res; 1994 Jul; 54(14):3824-30. PubMed ID: 8033102
[TBL] [Abstract][Full Text] [Related]
7. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
8. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance.
MacGrogan D; Levy A; Bostwick D; Wagner M; Wells D; Bookstein R
Genes Chromosomes Cancer; 1994 Jul; 10(3):151-9. PubMed ID: 7522037
[TBL] [Abstract][Full Text] [Related]
9. Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line.
Virgin JB; Hurley PM; Nahhas FA; Bebchuk KG; Mohamed AN; Sakr WA; Bright RK; Cher ML
Prostate; 1999 Sep; 41(1):49-57. PubMed ID: 10440875
[TBL] [Abstract][Full Text] [Related]
10. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
El Gammal AT; Brüchmann M; Zustin J; Isbarn H; Hellwinkel OJ; Köllermann J; Sauter G; Simon R; Wilczak W; Schwarz J; Bokemeyer C; Brümmendorf TH; Izbicki JR; Yekebas E; Fisch M; Huland H; Graefen M; Schlomm T
Clin Cancer Res; 2010 Jan; 16(1):56-64. PubMed ID: 20028754
[TBL] [Abstract][Full Text] [Related]
12. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
13. Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridisation and comparative genomic hybridisation.
Wilkens L; Benten D; Tchinda J; Brabant G; Pötter E; Dralle H; von Wasielewski R
Virchows Arch; 2000 Apr; 436(4):312-8. PubMed ID: 10834532
[TBL] [Abstract][Full Text] [Related]
14. Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization.
Fu W; Bubendorf L; Willi N; Moch H; Mihatsch MJ; Sauter G; Gasser TC
Urology; 2000 Nov; 56(5):880-5. PubMed ID: 11068328
[TBL] [Abstract][Full Text] [Related]
15. Genetic aberrations in prostate cancer by microarray analysis.
Saramäki OR; Porkka KP; Vessella RL; Visakorpi T
Int J Cancer; 2006 Sep; 119(6):1322-9. PubMed ID: 16642477
[TBL] [Abstract][Full Text] [Related]
16. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy.
Nakao K; Shibusawa M; Ishihara A; Yoshizawa H; Tsunoda A; Kusano M; Kurose A; Makita T; Sasaki K
Cancer; 2001 Feb; 91(4):721-6. PubMed ID: 11241239
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in hormone-refractory recurrent prostate carcinomas.
Nupponen NN; Kakkola L; Koivisto P; Visakorpi T
Am J Pathol; 1998 Jul; 153(1):141-8. PubMed ID: 9665474
[TBL] [Abstract][Full Text] [Related]
18. Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization.
Wolter H; Gottfried HW; Mattfeldt T
BJU Int; 2002 Feb; 89(3):310-6. PubMed ID: 11856117
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetics of prostate cancer.
Nupponen NN; Visakorpi T
Microsc Res Tech; 2000 Dec; 51(5):456-63. PubMed ID: 11074616
[TBL] [Abstract][Full Text] [Related]
20. Complex CGH alterations on chromosome arm 8p at candidate tumor suppressor gene loci in breast cancer cell lines.
Venter DJ; Ramus SJ; Hammet FM; de Silva M; Hutchins AM; Petrovic V; Price G; Armes JE
Cancer Genet Cytogenet; 2005 Jul; 160(2):134-40. PubMed ID: 15993269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
